Oncolytics Biotech (ONCY) Other Non Operating Income (2009 - 2025)

Oncolytics Biotech (ONCY) has 13 years of Other Non Operating Income data on file, last reported at $101728.9 in Q3 2025.

• On a quarterly basis, Other Non Operating Income rose 213.75% year-over-year to $101728.9 in Q3 2025; TTM through Sep 2025 was $136117.6, a 3.35% decrease from a year earlier, with the FY2025 full-year figure at $45000.0, down 98.42% from the prior year.
• Other Non Operating Income for Q3 2025 stood at $101728.9, up from -$203522.9 in the prior quarter.
• Over the last five years, Other Non Operating Income for ONCY reached as high as $1.2 million in Q3 2022 and fell as low as -$513622.0 in Q2 2021.
• Historically, Other Non Operating Income has averaged $73013.2 across 5 years, with a median of -$35542.7 in 2025.
• Across the five-year window, Other Non Operating Income soared 51768.92% in 2024 and slumped 251.28% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at -$258757.7 in 2021, then advanced by 21.99% to -$201856.6 in 2022, then tumbled by 42.64% to -$287937.9 in 2023, then soared by 194.97% to $273454.4 in 2024, then slumped by 62.8% to $101728.9 in 2025.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $101728.9 in Q3 2025, -$203522.9 in Q2 2025, and -$35542.7 in Q1 2025.